Tag: orphan drug designation
October 7, 2019
Matinas BioPharma Receives Orphan Drug Designation for MAT2203
The US Food and Drug Administration granted the company orphan drug designation for its MAT2203 treatment for cryptococcosis. September 9, 2019
Adaptimmune Therapeutics Receives Orphan Drug Designation
Adaptimmune Therapeutics (NASDAQ:ADAP) has announced that the US Food and Drug Administration (FDA) has granted it orphan drug designation for... July 24, 2019
Mustang Bio Receives Orphan Drug Designation for MB-102
Mustang Bio (NASDAQ:MBIO) announced it has received orphan drug designation from the US Food and Drug Administration (FDA) For its... July 23, 2019
La Jolla Pharmaceutical Company Receives Orphan Designation from FDA for LJPC-0118
La Jolla Pharmaceutical (NASDAQ:LJPC) has announced that the US Food and Drug Administration (FDA) has granted the company orphan drug...
June 12, 2019
Catalyst Pharmaceuticals Files Lawsuit Against FDA Over Rival Drug
The company is suing the regulatory agency over the approval of Jacobus Pharmaceutical's rival drug Ruzurgi. May 28, 2019
Applied Therapeutics Announces FDA Orphan Drug Designation for AT-007
Applied Therapeutics (NASDAQ:APLT) has announced that the US Food and Drug Administration (FDA) has granted the company orphan drug designation... February 7, 2019